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Myxoid Chondrosarcoma of the Sinonasal
Cavity in a Child: a Case Report
Chondrosarcomas are malignant tumors of cartilage that rarely involve the
sinonasal region, and myxoid chondrosarcoma is a rare histologic variant of
chondrosarcoma that usually occurs in the soft tissue of extremities. Although
several case reports and results of small series of chondrosarcomas in the
sinonasal region in children are available, myxoid type chondrosarcoma is
extremely rare. We recently experienced a case of low grade myxoid chondrosar-
coma involving the sinonasal cavity in a 10-year-old boy, and here we report its
radiologic-pathologic findings. In this case, chondroid calcification on CT and sep-
tal and marginal enhancement on MRI suggested a chondrosarcoma. Whole
body PET-CT demonstrated no definite metastatic lesion and a low peak stan-
dardized uptake value primary tumor. However, no definite distinguishing imaging
features were observed that distinguished low grade myxoid chondrosarcoma
from conventional chondrosarcoma. 
hondrosarcomas are malignant mesenchymal tumors of cartilage, and
usually involve the long bone and pelvis. Less than 10% of chondrosar-
comas are found in the head and neck region. Chondrosarcomas can
occur at any age, but the majority present between the 5th and 7th decades (1).
Therefore, chondrosarcomas of the head and neck in children are rare; only about 13
cases of sinonasal chondrosarcoma in children have been reported (1, 2). 
Myxoid chondrosarcoma is a rare histologic variant of chondrosarcoma, and is
characterized by abundant chondroid matrix and malignant chondroblastic cells
arranged in cords resembling chordoma (2, 3). Myxoid chondrosarcomas are typically
located in the limbs in older patients, and only rarely originate in the head and neck in
children (2). To the best of our knowledge, only one case report of myxoid type
chondrosarcoma in the sinonasal region in a child is available (2). 
We report a case of myxoid chondrosarcoma involving the sinonasal cavity in a child
and describe its computed tomography (CT), magnetic resonance imaging (MRI) and
whole body positron emission tomography-computed tomography (PET-CT) appear-
ances, in addition to histopathologic findings.
CASE REPORT
A 10-year-old boy presented with bloody rhinorrhea of one month duration from
the right side of the nasal cavity. On nasal endoscopy, a large, polypoid mass was
observed to fill the right nasal cavity causing deviation of the lateral nasal wall to the
right. CT showed a lobulated, low attenuating mass with ring and arc calcifications in
the right nasal cavity and nasal septum, measuring about 4.9 3.3 2.9 cm (Fig. 1).
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CThe mass extended beyond the nasal septum into the right
ethmoid sinus and had caused pressure erosion of the
adjacent bony margins of the cribriform plate and medial
orbital wall. However, no definite bony destruction was
demonstrated. After intravenous infusion of contrast
medium, subtle internal septal enhancement of the mass
was observed. Coronal and axial T2-weighted MR images
(TR/TE, 4128/100) revealed more accurately the anatomi-
cal relationships of the mass (Figs. 2A, B), which was
located in the right nasal cavity and nasal septum, and
extending into the right ethmoid sinus. The mass had
displaced and compressed the right medial orbital wall
laterally and the cribriform plate superiorly, and mass was
homogeneously hypointense on T1-weighted images (Fig.
2C) and heterogeneously hyperintense on T2-weighted
images (Figs. 2A, B). It showed mainly peripheral and
septal-like enhancement on contrast-enhanced T1-
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Fig. 1. Non-enhanced axial CT scan showing a lobulated hypoat-
tenuating mass in the right nasal cavity and nasal septum,
containing ring and arc calcifications (arrows). The bony margins
of the medial orbital wall were thin and expanded, without definite
evidence of bony destruction. 
AB
Fig. 2. A, B. Coronal and axial T2 weighted MR images (TR/TE, 4530/110) showing a high signal intensity mass located in the right
posterior nasal cavity and on the nasal septum, and extending into the right ethmoid sinus. Areas of low signal intensity (arrows) on T2-
weighted images corresponded to matrix mineralization on CT images. The mass displaced and compressed the right medial orbital wall
laterally and the cribriform plate superiorly. 
C. Axial T1 weighted image (TR/TE, 921/11) showing the homogeneously hypointense mass. 
D. Contrast-enhanced T1-weighted image showing peripheral and septal-like enhancement with a focal area of strong enhancement
(asterisk) at the anterior portion of the mass.
CDweighted images and regional inhomogeneously strong
enhancement at its anterosuperior portion (Fig. 2D). Areas
of low signal intensity were seen on T2-weighted MR
images (Fig. 2B), which corresponded to matrix mineraliza-
tion on CT images (Fig. 1). An endoscopic biopsy was
performed in the nasal cavity, and the preliminary
pathologic diagnosis was of myxoid chondrosarcoma or
chordoma, due to the presence of a cord-like cellular
arrangement with a myxoid background. Whole body
PET-CT with a low-dose CT protocol was performed at the
17th day after biopsy. PET-CT revealed a mild F18-
fluorodeoxyglucose (FDG) uptake area (pSUV, peak
standardized uptake value = 2.7) in the lesion without a
definite metastatic lesion (Fig. 3). 
The patient underwent subtotal resection of the mass;
some residual mass remained in the ethmoid sinus and
nasal septum. The removed tumor was a pale gray, soft to
firm, polypoid mass measuring 4.7 3.0 3.0 cm.
Histologically, there were scattered pleomorphic
chondroblasts with thin anastomosing strands surrounded
by a myxoid stroma; cellular areas were arranged in cords
(Fig. 4). The presence of a characteristic cord-like cellular
arrangement resembling chordoma and strong positivity
for S-100 protein and vimentin led to a final diagnosis of
myxoid chondrosarcoma. The low cellular atypia, few
mitoses, and low cellularity observed represented a low
grade tumor. We could not prove the presence of the
specific t (9; 26) translocation which is regarded as another
pathognomonic feature of myxoid chondrosarcoma
because the RT-PCR technique and primer required were
unavailable. 
After surgery, the patient underwent radiation therapy
on the remaining primary tumor, and subsequently the
remaining tumor showed a decreased size and enhance-
ment on follow up CT.
DISCUSSION
Myxoid chondrosarcoma is a rare histologic variant of
chondrosarcoma, and the vast majority of lesions arise in
the soft tissue of the extremities with the thigh being the
single most common location (3, 4). Myxoid chondrosar-
coma rarely originates in the head and neck and is
extremely rare in patients younger than 20 years of age.
These tumors typically possess a t(9; 22) translocation,
which is not seen in conventional chondrosarcoma. They
also have a quite different clinical course with a high rate
of local recurrence and eventually a high rate of late death
(5).
According to Kilpatrick et al. (6), the more aggressive
clinical behavior of myxoid chondrosarcoma is reflected by
its radiologic features, which include a permeative pattern
of osseous destruction and associated soft tissue mass.
Matrix mineralization is frequently apparent on CT scans,
though, it is not extensive. The extensive myxoid stroma
of myxoid chondrosarcoma has an exceptionally high
water content with low attenuation by CT and very high
signal intensity by T2-weighted MR (6), and this MRI
enhancement pattern of myxoid chondrosarcoma depends
on tumor heterogeneity (4). Although intralesional
hemorrhage is common pathologic finding, it is uncommon
by MRI. Extracompartmental extension, cortical destruc-
tion and a soft tissue mass were also found (4).
Murphey et al. (3) reported that regardless of specific
pathologic types, chondrosarcoma has features in common
with cartilaginous tumors as it has high water content, a
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Fig. 3. PET-CT image showing mild F18-fluorodeoxyglucose
(FDG) uptake (pSUV = 2.7) (arrows) in the right nasal cavity and
on the nasal septum. 
Fig. 4. Photomicrograph of the resected tumor (Hematoxylin &
Eosin,  400). A cord-like cellular arrangement of pleomorphic
chondroblasts (arrows) with thin anastomosing strands is shown
surrounded by myxoid stroma (asterisks). Myxoid Chondrosarcoma of Sinonasal Cavity in a Child
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lobular type architecture, and peripheral enchondral
calcification. The slow growth shown this tumor may
induce signs of pressure erosion on adjacent bone rather
than destruction.
Our case demonstrated very low attenuation on CT and
high signal intensity on T2-weighted MR images; represent-
ing the high water content of myxoid stroma. Some
portion of the mass in the nasal septum and ethmoid sinus
showed heterogeneously intense enhancement, and the
remaining portion in the right nasal cavity showed periph-
eral and septal-like enhancement. As reported by Tateishi
et al. (4), our case also showed some hemorrhagic foci
microscopically, did not show any evidence of hemorrhage
on MR or CT images. However, extracompartmental
extension was absent in our case. Only pressure erosions
were observed at adjacent bony structures (excepting the
nasal septum), rather than a permeative pattern of osseous
destruction, which is one of the features of myxoid
chondrosarcoma. In fact, our case demonstrates the typical
imaging findings of conventional chondrosarcoma rather
than any specific findings of myxoid chondrosarcoma.
The precise role of FDG-PET for bone and soft tissue
tumors has not been well established in pediatric oncology.
However, Brenner et al. (7) reported that the combination
of pSUV on PET imaging and histopathologic tumor
grading in chondrosarcoma might be helpful for determin-
ing a more accurate prognosis. Depending on pSUV
values, they divided chondrosarcomas into two groups, i.e.
low risk (low-grade irrespective of pSUV and intermediate-
or high-grade tumor with pSUV  4) and high risk
(intermediate- or high-grade tumor with pSUV > 4) (7).
Recent advances in imaging have allowed the acquisition
of physiological information in chondrosarcoma that
complements that structural detail provided by traditional
techniques, such as, dynamic contrast enhanced perfusion
MR and diffusion weighted imaging (DWI). By dynamic
contrast enhanced perfusion MR, chondrosarcoma shows
hypoperfusion and is essentially ‘cold’ (8). Quantitative
DWI may be useful for differentiating chondrosarcoma
from other poorly contrast-enhanced and T2-prolonged
bone masses because of its low apparent diffusion coeffi-
cient value (9).
The treatment of choice for chondrosarcomas is wide
local excision. Kawaguchi et al. (10) reported that wide
excision for myxoid chondrosarcoma was effective for
achieving local tumor control, irrespective of previous
excision or recurrence. Chemotherapy and radiation
therapy have limited roles in cases of chondrosarcoma, as
the disease is generally insensitive to these treatments.
However, radiation therapy may be used when a tumor
has been excised incompletely or is located in surgically
inaccessible region. The most frequent metastatic sites are
lung and regional lymph nodes (3). In particular, myxoid
chondrosarcoma has been reported to have a high
potential for pulmonary metastasis, regardless of its
histologic grade (3, 10).
In conclusion, although the occurrence of myxoid
chondrosarcoma arising from the sinonasal cavity is
extremely rare in children, chondrosarcoma can be
diagnosed in combination with chondroid calcification by
CT and by septal and marginal enhancement on MR. In
our case, low grade myxoid chondrosarcoma in the
sinonasal cavity had imaging features resembling those of
conventional chondrosarcoma, and showed no imaging
features that definitely distinguished it from conventional
chondrosarcoma. 
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